LYVE1 and neoplasm: Our methodology reveals β4 integrin throughout the tumor; however, within lymphatic vessels, there is differential distribution of β4 integrin with relative increases in β4 accumulation observed in lymphovascular areas proximal to Lyve1+ lymphatic endothelial cells (LECs) (Figure 1H, white arrow).